Clinical Trial

Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation

Study acronym: MS_Early_Rehab
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The overall purpose of this project is to develop and test an infrastructure that can ensure early and specialized rehabilitation for individuals with multiple sclerosis (MS) on their path to recovery from a relapse. If this project proves successful, it can therefore help optimize clinical practice and provide a significant contribution to the treatment of relapsing-remitting sclerosis.
Trial Details
NCT Number NCT06956326
Lead Sponsor Lars Hvid
Conditions Multiple Sclerosis
Enrollment 64 participants
Start Date 2025-05-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-04